BRASTER, the owner of a unique technology for breast cancer diagnostics, has signed an agreement with the Warsaw University of Technology to begin the next stage of works on using artificial intelligence for the automatic interpretation of examinations performed using the Braster device.
The preliminary research project, implemented by the Faculty of Electronics and Information Technology at the Warsaw University of Technology, lasted three months and was successfully completed in mid-December last year. The aim of the next stage of works is to develop dedicated algorithms for the automatic interpretation of thermographic examinations from the Tester device. According to the experts from the University, this stage will last approximately six to nine months.
"In an optimistic scenario, we will have the algorithms, which will enable the automatic identification of cancerous changes on thermographic images, ready in six months. This will be a milestone in the process of preparing our device for commercialization among women, primarily because the automatic interpretation of examinations constitutes one of the pillars of the Company’s strategy. We also expect the sensitivity of our device to increase further, even to over 90%.” - explains Marcin Halicki, President of the Board of BRASTER S.A.
According to the Company’s strategy for 2015–2021, published in November, the Braster device will be available for sale in the second half of 2016. It will first be available on the Polish market. In 2017, its distribution in Germany and the United Kingdom is projected to begin. A year later the device will be placed on the markets of, among others, other European Union countries and the United States.